Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Atopic Dermatitis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07643766
What this trial is testing

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enveda Therapeutics 200
Large-scale testing (Phase 3)UnknownNCT04283968
What this trial is testing

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Tel-Aviv Sourasky Medical Center 50
Not applicableNot Yet RecruitingNCT07741838
What this trial is testing

Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)

Who this might be right for
Atopic Dermatitis
AbbVie 900
Large-scale testing (Phase 3)Study completedNCT04626297
What this trial is testing

Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 254
Early research (Phase 1)Ended earlyNCT06469385
What this trial is testing

Topical ENS-002 for Atopic Dermatitis in Adults

Who this might be right for
Atopic DermatitisAtopic Dermatitis Eczema
Concerto Biosciences 9
Testing effectiveness (Phase 2)Study completedNCT05717920
What this trial is testing

A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)

Who this might be right for
Atopic Dermatitis
Aldeyra Therapeutics, Inc. 8
Early research (Phase 1)Study completedNCT02376049
What this trial is testing

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
LEO Pharma 30
Testing effectiveness (Phase 2)Ended earlyNCT05999799
What this trial is testing

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 161
Not applicableStudy completedNCT05833880
What this trial is testing

Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Central Hospital, Nancy, France 89
Large-scale testing (Phase 3)UnknownNCT04717310
What this trial is testing

Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Reistone Biopharma Company Limited 645
Testing effectiveness (Phase 2)WithdrawnNCT02144142
What this trial is testing

Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisEczema
University of California, San Diego
Testing effectiveness (Phase 2)Study completedNCT04598269
What this trial is testing

Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 50
Large-scale testing (Phase 3)Study completedNCT03334435
What this trial is testing

Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 1,645
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782476
What this trial is testing

Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Health Adult SubjectsAtopic Dermatitis (AD)
Helixon Biotechnology (Suzhou) Co., Ltd 67
Not applicableStudy completedNCT05989932
What this trial is testing

Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

Who this might be right for
Atopic Dermatitis
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse 146
Testing effectiveness (Phase 2)Study completedNCT06012812
What this trial is testing

Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Shanghai Hengrui Pharmaceutical Co., Ltd. 79
Not applicableActive Not RecruitingNCT05669794
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

Who this might be right for
Atopic Dermatitis
AbbVie 300
Testing effectiveness (Phase 2)Study completedNCT01859988
What this trial is testing

Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 380
Large-scale testing (Phase 3)Study completedNCT04360187
What this trial is testing

Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 391
Not applicableStudy completedNCT07194421
What this trial is testing

In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin

Who this might be right for
Atopic Dermatitis (AD)SCORAD Index(15-25)
Pierre Fabre Dermo Cosmetique 42
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation